Lowering serum uric acid levels: What is the optimal target for improving clinical outcomes in gout?

Authors

  • Fernando Perez-Ruiz,

    1. Hospital de Cruces, Baracaldo, Pais Vasco, Spain
    Search for more papers by this author
    • Dr. Perez-Ruiz has served on advisory boards for and has received consultancy fees and/or honoraria (less than $10,000 each) from Ipsen and Savient.

  • Frédéric Lioté

    Corresponding author
    1. Fédération de Rhumatologie, INSERM U606 (IFR 139), Hôpital Lariboisière, Assistance Publique Hôpitaux de Paris, and Université Médecine Paris 7 Denis-Diderot, Paris, France
    • Fédération de Rhumatologie, INSERM U606 (IFR 139), Centre de Rhumatologie Viggo-Petersen, Hôpital Lariboisière, Assistance Publique-Hôpitaux de Paris, 2 rue Ambroise Paré, 75010 Paris, France
    Search for more papers by this author

Ancillary